Amerisourcebergen Corp
LSE:0HF3
Gross Margin
Amerisourcebergen Corp
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
53.2B USD |
3%
|
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
85.6B USD |
4%
|
|
US |
![]() |
Cencora Inc
NYSE:COR
|
54.1B USD |
3%
|
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
31.2B USD |
3%
|
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
34.6B AUD |
9%
|
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
64.6B CNY |
32%
|
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
30%
|
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
13%
|
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
7.9B USD |
32%
|
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53.1B CNY |
11%
|
|
CN |
![]() |
Sinopharm Group Co Ltd
HKEX:1099
|
55.7B HKD |
8%
|
Amerisourcebergen Corp
Glance View
AmerisourceBergen Corp., a titan in the realm of pharmaceutical services, orchestrates the flow of medications across a vast and intricate network. Rooted in Chesterbrook, Pennsylvania, the company has cemented its place as a critical link in the healthcare supply chain. Serving as a bridge between pharmaceutical manufacturers and a wide array of healthcare providers like hospitals, clinics, and pharmacies, AmerisourceBergen leverages its expansive distribution infrastructure to ensure that medications and health products reach their destinations efficiently and reliably. The company's operations are bolstered by its strategic partnerships and collaboration with a plethora of healthcare entities, enabling it to integrate seamlessly into the delivery systems that support patient care. At its core, AmerisourceBergen turns the complexity of healthcare logistics into a streamlined process, generating revenue primarily through the distribution of pharmaceuticals. It purchases medications from manufacturers, sells them at a markup to healthcare providers, and in doing so, balances a robust supply chain fueled by efficiency and scale. But the story doesn't end at distribution; the company has expanded its reach through value-added services such as consulting, data analytics, and patient support services that further solidify its role in the healthcare ecosystem. Whether navigating regulatory environments or advising on patient care strategies, AmerisourceBergen positions itself as not just a distributor, but a partner in health. Through this dual approach of distribution and strategic services, the company ensures it remains vital to both manufacturers and healthcare providers, creating a sustainable business model that capitalizes on both volume and innovation.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Amerisourcebergen Corp's most recent financial statements, the company has Gross Margin of 3.3%.